A method for preparing a clear and stable enoxaparin sodium injection
Through ultrasonic dispersion method and pulsed electric field treatment, antioxidants and buffers were added, and supercritical carbon dioxide and pretreated activated carbon filtration was solved, and the stability and purity of enoxaparin sodium injection was achieved, and a clear and stable injection was achieved liquid preparation.
Patent Information
- Application Number
- CN202410510330.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-26
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-04-26
AI Technical Summary
The existing enoxaparin sodium injection has shortcomings in pH, color and activity stability, especially in accelerated experiments, its color will deepen, its activity will decrease, and it is more sensitive to strong acids, strong alkalis and strong oxidation, affecting product quality.
The crude enoxaparin product was treated in sodium chloride solution by ultrasonic dispersion, and the addition of anhydrous ethanol and methanol for pulsed electric field treatment. Then glutathione, methionine and aminolated konjac polysaccharide were added, and the pH was adjusted using a supercritical carbon dioxide mixture. And it is filtered and filled with pretreated injection activated carbon and nanotitanium dioxide-calcium alginate charged microporous filter membrane to ensure the stability of the injection.
It has achieved clarification and stability of enoxaparin sodium injection, improved the purity and stability of the product, reduced the introduction of impurities, and extended the service life of the product.
Smart Images

Figure BDA0004811634450000161 
Figure BDA0004811634450000171
Abstract
Description
Technical Field
[0001] The invention relates to a method for preparing a clear and stable enoxaparin sodium injection, belonging to the technical field of pharmaceutical preparations. Background Art
[0002] Heparin is the first choice of anticoagulant drugs, which has anticoagulant, antithrombotic, and lipid-lowering effects, but also has defects such as low bioavailability and large side effects, which seriously limit the clinical application of heparin. Low molecular weight heparin LMWH belongs to a new generation of anticoagulant drugs, which has better antithrombotic effect than heparin, lower anticoagulant effect than heparin, high bioavailability, long half-life in vivo, low bleeding tendency, easy oral absorption, and has better clinical application prospects.
[0003] Specifically, low molecular weight heparin is a low molecular weight component obtained when separating ordinary heparin, or a small molecule fragment produced after heparin cleavage, which is about 1 / 3 of the length of ordinary heparin. Enoxaparin sodium is a type of low molecular weight heparin and is widely used in clinical practice. The main mechanism of action of enoxaparin sodium is to inhibit the activity of factor Xa and factor IIa by binding to antithrombin and its complex. Enoxaparin sodium has strong anti-Xa activity and low anti-IIa activity. Therefore, compared with ordinary heparin, it has the advantages of low anticoagulation, high antithrombotic, high bioavailability, long action time, easy use and less bleeding effect.
[0004] There are two main methods for preparing enoxaparin sodium: chemical cleavage and enzymatic degradation. Among them, the enzymatic degradation method has a high cost and limited industrialization. Currently, the chemical cleavage method is the main preparation method for enoxaparin sodium.
[0005] The usual production process of enoxaparin sodium injection is: dissolving the enoxaparin sodium raw material in the cooled water for injection, then aseptically filtering and filling, and finally inspecting and packaging. However, the enoxaparin sodium injection produced by the existing process is poor in pH, color and activity stability, especially in the accelerated experiment process, in the later stage of the accelerated experiment, its color is often darker than the corresponding quality standard, and the activity will decrease to a certain extent, and the pH will decrease to a large extent. Strong degradation tests show that enoxaparin sodium is sensitive to strong acids, strong bases and strong oxidation, and the main reactions are glycosidic bond breakage, desulfurization, decreased activity, increased light absorption, etc. The influencing factor test shows that enoxaparin sodium can withstand light for a short time, but it should be avoided as much as possible, and high temperature should be avoided to avoid changes in sample properties and affect product quality.
[0006] Patent application CN113413364A discloses an enoxaparin sodium injection, which effectively reduces the oxygen content in the solution by adding a water-soluble antioxidant sodium bisulfite, and controls the pH by adding a phosphate buffer, thereby improving the stability of the injection. However, sodium bisulfite is generally used in food and chemical products, and contains many impurities, which does not meet the injection grade requirements and brings certain quality risks. Summary of the invention
[0007] The purpose of the present invention is to overcome the deficiencies of the prior art and provide a method for preparing a clear and stable enoxaparin sodium injection.
[0008] To achieve the above object, the present invention adopts the following technical solutions:
[0009] A method for preparing a clear and stable enoxaparin sodium injection, the specific steps are as follows:
[0010] (1) firstly ultrasonically disperse the crude enoxaparin sodium in a sodium chloride solution to obtain a crude solution, then add anhydrous ethanol to the crude solution, treat it with a pulse electric field, add methanol, let it stand, separate the solid from the liquid, take out the precipitate, and dry it to obtain a refined enoxaparin sodium;
[0011] (2) Take 70-80% of the prescription amount of water for injection, boil it and place it in a batching tank, cool it naturally to 30-40° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved;
[0012] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0013] (4) Finally, add the pretreated activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0014] Preferably, the injection comprises, by weight percentage: 9.5-10% refined enoxaparin sodium, 0.5-0.8% glutathione, 0.4-0.7% methionine, 0.3-0.5% amino konjac polysaccharide, and the remainder is water for injection; wherein the anti-Xa titer of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa titer is 26 IU / mg.
[0015] Preferably, the amino konjac polysaccharide is prepared by the following method: first, konjac polysaccharide is added to DMSO, stirred at 45°C for 3 hours, naturally cooled to room temperature, carbonyldiimidazole is added, stirred and reacted at room temperature for 3 hours, then ethylenediamine is added, stirring and reacting is continued for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyldiimidazole, and ethylenediamine is 1:10-12:2:8-10.
[0016] Preferably, in step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization, and the specific method is as follows:
[0017] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0018] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0019] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0020] Preferably, in step (1), the usage ratio of crude enoxaparin sodium, sodium chloride solution, anhydrous ethanol and methanol is 1 g: 7-9 mL: 45-50 mL: 10-15 mL, wherein the mass concentration of the sodium chloride solution is 8-10%.
[0021] Preferably, in step (1), the process conditions for ultrasonic dispersion are: 500-600W ultrasonic oscillation treatment for 30-40 minutes.
[0022] Preferably, in step (1), the process conditions of the pulse electric field treatment are: electric field intensity 10-20 kV / cm, electric field frequency 40-50 Hz, pulse width 2 μs, and treatment time 900-1000 μs.
[0023] Preferably, in step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4 to 5 hours.
[0024] Preferably, in step (1), the drying process conditions are: vacuum drying at 60-70° C. for 7-8 hours.
[0025] Preferably, in step (2), the stirring process conditions are: stirring at 300-400 r / min for 40-50 minutes.
[0026] Preferably, in step (3), the specific method of mixing supercritical carbon dioxide is: injecting carbon dioxide, pressurizing to 15-20 MPa, and stirring at 300-400 r / min for 1-2 hours under this condition.
[0027] Preferably, in step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0028] Preferably, in step (4), the pretreatment method of the activated carbon for injection is as follows: first, carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution to remove residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, purified carbon dioxide is passed into it at 50°C, the flow rate is 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20°C and allowed to stand for 8 hours.
[0029] Preferably, in step (4), the process conditions for stirring adsorption are: stirring at 300-400 r / min for 20-30 minutes.
[0030] Preferably, in step (4), the nano-titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano-titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0031] Further preferably, the nano titanium dioxide-calcium alginate sol is prepared by the following method: dissolving 100 mL of butyl titanate in 100 mL of anhydrous ethanol to obtain solution A; adding 50 mL of anhydrous ethanol to 300 mL of ionized water, then adding 200 mL of glacial acetic acid, stirring and mixing to obtain solution B; heating solution A to 40° C. in a water bath, adding solution B dropwise while stirring, adjusting the pH to 3.0 with 1 mol / L hydrochloric acid solution, adding 1 g of calcium alginate, stirring to fully dissolve it, and obtaining the solution.
[0032] Beneficial effects of the present invention:
[0033] The invention firstly disperses the crude product of enoxaparin sodium in a sodium chloride solution by ultrasonic to obtain a crude product solution, then adds anhydrous ethanol to the crude product solution, treats it by pulse electric field, adds methanol, stands, separates the solid and liquid to obtain the precipitate, and dries to obtain a refined product of enoxaparin sodium; takes 70-80% of the prescribed amount of water for injection, boils it and places it in a batching tank, naturally cools it to 30-40°C under nitrogen protection, adds glutathione, methionine, and amino konjac polysaccharide, and stirs until it is completely dissolved; then adds the refined product of enoxaparin sodium, mixes it evenly with supercritical carbon dioxide, and adjusts the pH; finally, adds pretreated activated carbon for injection, stirs for adsorption, recovers the activated carbon, supplements the water for injection to the full amount of the prescription, stirs and mixes, filters it with a charged microporous filter membrane of nano titanium dioxide-calcium alginate, and aseptically fills it to obtain an injection. The enoxaparin sodium injection obtained by the invention is clear and stable, and has high product quality.
[0034] The invention firstly refines the crude enoxaparin sodium, ultrasonic dispersion helps to fully free impurities in the crude enoxaparin sodium, adds anhydrous ethanol to carry out pulse electric field treatment, precipitates the enoxaparin sodium, then adds methanol, and the remaining enoxaparin sodium continues to precipitate, and the step-by-step precipitation of anhydrous ethanol and methanol combined with pulse electric field treatment helps to reduce impurity doping and improve the purity of the refined product.
[0035] The invention adds glutathione, methionine and amino konjac polysaccharide, which have a synergistic effect, play an antioxidant role and help improve the stability of the injection.
[0036] The present invention adopts supercritical carbon dioxide mixing, which is fully mixed, is conducive to the anti-oxidation effect, and reduces the chance of impurities being introduced.
[0037] The present invention performs stirring adsorption after pretreating the injection activated carbon, has a better impurity adsorption effect, improves pyrogen adsorption, and does not bring other impurities due to the injection activated carbon, thereby ensuring product purity and avoiding affecting stability.
[0038] The present invention utilizes nano titanium dioxide-calcium alginate charged microporous filter membrane for filtration, which has a large specific surface area and can adsorb fine impurities including bacteria and viruses, thereby further improving the stability of the product. DETAILED DESCRIPTION
[0039] The present invention is further described below in conjunction with embodiments. It should be noted that the following description is only for explaining the present invention and does not limit its contents.
[0040] Embodiment 1:
[0041] A method for preparing a clear and stable enoxaparin sodium injection, the specific steps are as follows:
[0042] (1) First, 1 kg of crude enoxaparin sodium was ultrasonically dispersed in 7 L of 8% sodium chloride solution to obtain a crude solution, then 45 L of anhydrous ethanol was added to the crude solution, pulsed electric field treatment was performed, 10 L of methanol was added, the solution was allowed to stand, solid-liquid separation was performed to obtain a precipitate, and the precipitate was dried to obtain a refined enoxaparin sodium solution;
[0043] (2) Take 70% of the prescribed amount of water for injection, boil it and place it in a batching tank, cool it naturally to 30° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved;
[0044] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0045] (4) Finally, add the pretreated activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0046] In terms of weight percentage, the injection comprises: 9.5% of refined enoxaparin sodium, 0.5% of glutathione, 0.4% of methionine, 0.3% of amino konjac polysaccharide, and the remainder is water for injection; wherein the anti-Xa titer of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa titer is 26 IU / mg.
[0047] The amino konjac polysaccharide is prepared by the following method: firstly, konjac polysaccharide is added to DMSO, stirred at 45°C for 3 hours, naturally cooled to room temperature, carbonyldiimidazole is added, stirred and reacted at room temperature for 3 hours, then ethylenediamine is added, stirred and reacted for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain the amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyldiimidazole and ethylenediamine is 1:10:2:8.
[0048] In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization. The specific method is as follows:
[0049] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0050] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0051] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0052] In step (1), the process conditions for ultrasonic dispersion are: 500W ultrasonic oscillation treatment for 30 minutes.
[0053] In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 10 kV / cm, electric field frequency 40 Hz, pulse width 2 μs, and treatment time 900 μs.
[0054] In step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4 hours.
[0055] In step (1), the drying process conditions are: vacuum drying at 60° C. for 7 hours.
[0056] In step (2), the stirring process conditions are: stirring at 300 r / min for 40 minutes.
[0057] In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 15 MPa, and stirring at 300 r / min for 1 hour under this condition.
[0058] In step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0059] In step (4), the pretreatment method of the activated carbon for injection is as follows: first, the carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution for removal of residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, and purified carbon dioxide is passed into it at 50° C., with a flow rate of 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20° C., and the mixture is allowed to stand for 8 hours.
[0060] In step (4), the process conditions for stirring adsorption are: stirring at 300 r / min for 20 minutes.
[0061] In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0062] The nano titanium dioxide-calcium alginate sol is prepared by the following method: 100 mL of butyl titanate is dissolved in 100 mL of anhydrous ethanol to obtain solution A; 50 mL of anhydrous ethanol is added into 300 mL of ionized water, and then 200 mL of glacial acetic acid is added, and the mixture is stirred to obtain solution B; solution A is heated to 40° C. in a water bath, solution B is added dropwise while being stirred, pH is adjusted to 3.0 with a 1 mol / L hydrochloric acid solution, 1 g of calcium alginate is added, and the mixture is stirred to fully dissolve the solution, thereby obtaining the nano titanium dioxide-calcium alginate sol.
[0063] Embodiment 2:
[0064] A method for preparing a clear and stable enoxaparin sodium injection, the specific steps are as follows:
[0065] (1) First, 1 kg of crude enoxaparin sodium was ultrasonically dispersed in 9 L of 10% sodium chloride solution to obtain a crude solution, and then 50 L of anhydrous ethanol was added to the crude solution, pulsed electric field treatment was performed, 15 L of methanol was added, and the solution was allowed to stand, solid-liquid separation was performed to obtain a precipitate, and the precipitate was dried to obtain a refined enoxaparin sodium solution;
[0066] (2) Take 80% of the prescribed amount of water for injection, boil it and place it in a batching tank, cool it naturally to 40° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved;
[0067] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0068] (4) Finally, add the pretreated activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0069] The injection comprises, by weight percentage, 10% refined enoxaparin sodium, 0.8% glutathione, 0.7% methionine, 0.5% amino konjac polysaccharide, and the remainder water for injection; wherein the anti-Xa potency of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa potency is 26 IU / mg.
[0070] The amino konjac polysaccharide is prepared by the following method: firstly, konjac polysaccharide is added to DMSO, stirred at 45°C for 3 hours, naturally cooled to room temperature, carbonyldiimidazole is added, stirred and reacted at room temperature for 3 hours, then ethylenediamine is added, stirred and reacted for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain the amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyldiimidazole and ethylenediamine is 1:12:2:10.
[0071] In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization. The specific method is as follows:
[0072] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0073] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0074] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0075] In step (1), the process conditions for ultrasonic dispersion are: 600W ultrasonic oscillation treatment for 40 minutes.
[0076] In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 20 kV / cm, electric field frequency 50 Hz, pulse width 2 μs, and treatment time 1000 μs.
[0077] In step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 5 hours.
[0078] In step (1), the drying process conditions are: vacuum drying at 70° C. for 8 hours.
[0079] In step (2), the stirring process conditions are: stirring at 400 r / min for 50 minutes.
[0080] In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 20 MPa, and stirring at 400 r / min for 2 hours under this condition.
[0081] In step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0082] In step (4), the pretreatment method of the activated carbon for injection is as follows: first, the carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution for removal of residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, and purified carbon dioxide is passed into it at 50° C., with a flow rate of 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20° C., and the mixture is allowed to stand for 8 hours.
[0083] In step (4), the process conditions for stirring adsorption are: stirring at 400 r / min for 30 minutes.
[0084] In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0085] The nano titanium dioxide-calcium alginate sol is prepared by the following method: 100 mL of butyl titanate is dissolved in 100 mL of anhydrous ethanol to obtain solution A; 50 mL of anhydrous ethanol is added into 300 mL of ionized water, and then 200 mL of glacial acetic acid is added, and the mixture is stirred to obtain solution B; solution A is heated to 40° C. in a water bath, solution B is added dropwise while being stirred, pH is adjusted to 3.0 with a 1 mol / L hydrochloric acid solution, 1 g of calcium alginate is added, and the mixture is stirred to fully dissolve the solution, thereby obtaining the nano titanium dioxide-calcium alginate sol.
[0086] Embodiment 3:
[0087] A method for preparing a clear and stable enoxaparin sodium injection, the specific steps are as follows:
[0088] (1) First, 1 kg of crude enoxaparin sodium was ultrasonically dispersed in 8 L of 9% sodium chloride solution to obtain a crude solution, and then 48 L of anhydrous ethanol was added to the crude solution, pulsed electric field treatment was performed, 12 L of methanol was added, the solution was allowed to stand, solid-liquid separation was performed to obtain a precipitate, and the precipitate was dried to obtain a refined enoxaparin sodium solution;
[0089] (2) Take 75% of the prescribed amount of water for injection, boil it and place it in a batching tank, cool it naturally to 35° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved;
[0090] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0091] (4) Finally, add the pretreated activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0092] The injection comprises, by weight percentage, 10% refined enoxaparin sodium, 0.7% glutathione, 0.5% methionine, 0.4% amino konjac polysaccharide, and the remainder water for injection; wherein the anti-Xa potency of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa potency is 26 IU / mg.
[0093] The amino konjac polysaccharide is prepared by the following method: first, konjac polysaccharide is added to DMSO, stirred at 45°C for 3 hours, naturally cooled to room temperature, carbonyldiimidazole is added, stirred and reacted at room temperature for 3 hours, then ethylenediamine is added, stirred and reacted for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain the amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyldiimidazole and ethylenediamine is 1:11:2:9.
[0094] In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization. The specific method is as follows:
[0095] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0096] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0097] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0098] In step (1), the process conditions for ultrasonic dispersion are: 600W ultrasonic oscillation treatment for 35 minutes.
[0099] In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 15 kV / cm, electric field frequency 45 Hz, pulse width 2 μs, and treatment time 1000 μs.
[0100] In step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4.5 hours.
[0101] In step (1), the drying process conditions are: vacuum drying at 65° C. for 7.5 hours.
[0102] In step (2), the stirring process conditions are: stirring at 400 r / min for 45 minutes.
[0103] In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 18 MPa, and stirring at 400 r / min for 2 hours under this condition.
[0104] In step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0105] In step (4), the pretreatment method of the activated carbon for injection is as follows: first, the carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution for removal of residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, and purified carbon dioxide is passed into it at 50° C., with a flow rate of 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20° C., and the mixture is allowed to stand for 8 hours.
[0106] In step (4), the process conditions for stirring adsorption are: stirring at 400 r / min for 25 minutes.
[0107] In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0108] The nano titanium dioxide-calcium alginate sol is prepared by the following method: 100 mL of butyl titanate is dissolved in 100 mL of anhydrous ethanol to obtain solution A; 50 mL of anhydrous ethanol is added into 300 mL of ionized water, and then 200 mL of glacial acetic acid is added, and the mixture is stirred to obtain solution B; solution A is heated to 40° C. in a water bath, solution B is added dropwise while being stirred, pH is adjusted to 3.0 with a 1 mol / L hydrochloric acid solution, 1 g of calcium alginate is added, and the mixture is stirred to fully dissolve the solution, thereby obtaining the nano titanium dioxide-calcium alginate sol.
[0109] Comparative Example 1
[0110] A method for preparing enoxaparin sodium injection, the specific steps are as follows:
[0111] (1) First, 1 kg of crude enoxaparin sodium was ultrasonically dispersed in 7 L of 8% sodium chloride solution to obtain a crude solution, and then 45 L of anhydrous ethanol and 10 L of methanol were added to the crude solution, and the solution was allowed to stand for solid-liquid separation to obtain a precipitate, which was dried to obtain a refined enoxaparin sodium;
[0112] (2) Take 70% of the prescribed amount of water for injection, boil it and place it in a batching tank, cool it naturally to 30° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved;
[0113] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0114] (4) Finally, add the pretreated activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0115] In terms of weight percentage, the injection comprises: 9.5% of refined enoxaparin sodium, 0.5% of glutathione, 0.4% of methionine, 0.3% of amino konjac polysaccharide, and the remainder is water for injection; wherein the anti-Xa titer of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa titer is 26 IU / mg.
[0116] The amino konjac polysaccharide is prepared by the following method: firstly, konjac polysaccharide is added to DMSO, stirred at 45°C for 3 hours, naturally cooled to room temperature, carbonyldiimidazole is added, stirred and reacted at room temperature for 3 hours, then ethylenediamine is added, stirred and reacted for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain the amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyldiimidazole and ethylenediamine is 1:10:2:8.
[0117] In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization. The specific method is as follows:
[0118] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0119] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0120] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0121] In step (1), the process conditions for ultrasonic dispersion are: 500W ultrasonic oscillation treatment for 30 minutes.
[0122] In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 10 kV / cm, electric field frequency 40 Hz, pulse width 2 μs, and treatment time 900 μs.
[0123] In step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4 hours.
[0124] In step (1), the drying process conditions are: vacuum drying at 60° C. for 7 hours.
[0125] In step (2), the stirring process conditions are: stirring at 300 r / min for 40 minutes.
[0126] In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 15 MPa, and stirring at 300 r / min for 1 hour under this condition.
[0127] In step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0128] In step (4), the pretreatment method of the activated carbon for injection is as follows: first, the carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution for removal of residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, and purified carbon dioxide is passed into it at 50° C., with a flow rate of 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20° C., and the mixture is allowed to stand for 8 hours.
[0129] In step (4), the process conditions for stirring adsorption are: stirring at 300 r / min for 20 minutes.
[0130] In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0131] The nano titanium dioxide-calcium alginate sol is prepared by the following method: 100 mL of butyl titanate is dissolved in 100 mL of anhydrous ethanol to obtain solution A; 50 mL of anhydrous ethanol is added into 300 mL of ionized water, and then 200 mL of glacial acetic acid is added, and the mixture is stirred to obtain solution B; solution A is heated to 40° C. in a water bath, solution B is added dropwise while being stirred, pH is adjusted to 3.0 with a 1 mol / L hydrochloric acid solution, 1 g of calcium alginate is added, and the mixture is stirred to fully dissolve the solution, thereby obtaining the nano titanium dioxide-calcium alginate sol.
[0132] Comparative Example 2
[0133] A method for preparing enoxaparin sodium injection, the specific steps are as follows:
[0134] (1) First, 1 kg of crude enoxaparin sodium was ultrasonically dispersed in 7 L of 8% sodium chloride solution to obtain a crude solution, then 45 L of anhydrous ethanol was added to the crude solution, pulsed electric field treatment was performed, 10 L of methanol was added, the solution was allowed to stand, solid-liquid separation was performed to obtain a precipitate, and the precipitate was dried to obtain a refined enoxaparin sodium solution;
[0135] (2) Take 70% of the prescribed amount of water for injection, boil it and place it in a batching tank, cool it naturally to 30°C under nitrogen protection, add glutathione and methionine, and stir until they are completely dissolved;
[0136] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0137] (4) Finally, add the pretreated activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0138] In terms of weight percentage, the injection comprises: 9.5% refined enoxaparin sodium, 0.5% glutathione, 0.4% methionine, and the remainder is water for injection; wherein the anti-Xa potency of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa potency is 26 IU / mg.
[0139] In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization. The specific method is as follows:
[0140] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0141] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0142] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0143] In step (1), the process conditions for ultrasonic dispersion are: 500W ultrasonic oscillation treatment for 30 minutes.
[0144] In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 10 kV / cm, electric field frequency 40 Hz, pulse width 2 μs, and treatment time 900 μs.
[0145] In step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4 hours.
[0146] In step (1), the drying process conditions are: vacuum drying at 60° C. for 7 hours.
[0147] In step (2), the stirring process conditions are: stirring at 300 r / min for 40 minutes.
[0148] In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 15 MPa, and stirring at 300 r / min for 1 hour under this condition.
[0149] In step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0150] In step (4), the pretreatment method of the activated carbon for injection is as follows: first, the carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution for removal of residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, and purified carbon dioxide is passed into it at 50° C., with a flow rate of 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20° C., and the mixture is allowed to stand for 8 hours.
[0151] In step (4), the process conditions for stirring adsorption are: stirring at 300 r / min for 20 minutes.
[0152] In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0153] The nano titanium dioxide-calcium alginate sol is prepared by the following method: 100 mL of butyl titanate is dissolved in 100 mL of anhydrous ethanol to obtain solution A; 50 mL of anhydrous ethanol is added into 300 mL of ionized water, and then 200 mL of glacial acetic acid is added, and the mixture is stirred to obtain solution B; solution A is heated to 40° C. in a water bath, solution B is added dropwise while being stirred, pH is adjusted to 3.0 with a 1 mol / L hydrochloric acid solution, 1 g of calcium alginate is added, and the mixture is stirred to fully dissolve the solution, thereby obtaining the nano titanium dioxide-calcium alginate sol.
[0154] Comparative Example 3
[0155] A method for preparing enoxaparin sodium injection, the specific steps are as follows:
[0156] (1) First, 1 kg of crude enoxaparin sodium was ultrasonically dispersed in 7 L of 8% sodium chloride solution to obtain a crude solution, then 45 L of anhydrous ethanol was added to the crude solution, pulsed electric field treatment was performed, 10 L of methanol was added, the solution was allowed to stand, solid-liquid separation was performed to obtain a precipitate, and the precipitate was dried to obtain a refined enoxaparin sodium solution;
[0157] (2) Take 70% of the prescribed amount of water for injection, boil it and place it in a batching tank, cool it naturally to 30° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved;
[0158] (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH;
[0159] (4) Finally, add activated carbon for injection, stir for adsorption, recover the activated carbon, make up the amount of water for injection to the full amount of the prescription, stir and mix, filter through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically fill to obtain the injection solution.
[0160] In terms of weight percentage, the injection comprises: 9.5% of refined enoxaparin sodium, 0.5% of glutathione, 0.4% of methionine, 0.3% of amino konjac polysaccharide, and the remainder is water for injection; wherein the anti-Xa titer of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa titer is 26 IU / mg.
[0161] The amino konjac polysaccharide is prepared by the following method: firstly, konjac polysaccharide is added to DMSO, stirred at 45°C for 3 hours, naturally cooled to room temperature, carbonyldiimidazole is added, stirred and reacted at room temperature for 3 hours, then ethylenediamine is added, stirred and reacted for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain the amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyldiimidazole and ethylenediamine is 1:10:2:8.
[0162] In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification, and depolymerization. The specific method is as follows:
[0163] (a) 1 kg of heparin sodium is dissolved in 20 L of purified water to obtain a heparin sodium solution, 2.5 kg of benzethonium chloride is dissolved in 20 L of purified water to obtain a benzethonium chloride solution, the benzethonium chloride solution is added to the heparin sodium solution, the reaction is stirred for 30 minutes, 60 L of purified water is added, stirred for 10 minutes, left to stand for 30 minutes, filtered to obtain a filter cake, washed 3 times with purified water, and dried under vacuum at 60 ° C for 10 hours to obtain heparin benzethonium chloride salt;
[0164] (b) 2.1 kg of heparin benzethonium chloride was added to 20 L of dichloromethane, heated to 35° C. with stirring, and kept warm and stirred for 1 hour. 9 kg of benzyl chloride was added, and kept warm and stirred for 25 hours. An 8% sodium acetate methanol solution of equal volume to the reaction solution was added, and kept warm and stirred for 30 minutes. The filter cake was filtered, washed with methanol 3 times, and dried in vacuum at room temperature for 10 hours to obtain heparin benzyl ester;
[0165] (c) 1.3 kg of heparin benzyl ester was added to 10 L of purified water, stirred and heated to 60°C to obtain a heparin benzyl ester solution; 150 g of sodium hydroxide was added to 1 L of purified water, stirred and heated to 60°C to obtain a sodium hydroxide solution; the sodium hydroxide solution was added to the heparin benzyl ester solution, stirred and reacted at 60°C for 2 hours, cooled naturally to room temperature, adjusted pH to 6 with 0.1 mol / L hydrochloric acid solution, stirred for 5 minutes, and filtered to obtain the filtrate; 0.5 kg of sodium chloride was added to the filtrate, stirred for 30 minutes, 5 L of methanol was added, stirred for 5 minutes, filtered to obtain the filter cake, and vacuum dried at 60°C for 8 hours to obtain the crude enoxaparin sodium. (The stirring rate during the preparation process was 300 r / min)
[0166] In step (1), the process conditions for ultrasonic dispersion are: 500W ultrasonic oscillation treatment for 30 minutes.
[0167] In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 10 kV / cm, electric field frequency 40 Hz, pulse width 2 μs, and treatment time 900 μs.
[0168] In step (1), the feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4 hours.
[0169] In step (1), the drying process conditions are: vacuum drying at 60° C. for 7 hours.
[0170] In step (2), the stirring process conditions are: stirring at 300 r / min for 40 minutes.
[0171] In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 15 MPa, and stirring at 300 r / min for 1 hour under this condition.
[0172] In step (3), the pH is adjusted to 7.0 using 0.1 mol / L hydrochloric acid solution or 0.1 mol / L sodium hydroxide solution.
[0173] In step (4), the process conditions for stirring adsorption are: stirring at 300 r / min for 20 minutes.
[0174] In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
[0175] The nano titanium dioxide-calcium alginate sol is prepared by the following method: 100 mL of butyl titanate is dissolved in 100 mL of anhydrous ethanol to obtain solution A; 50 mL of anhydrous ethanol is added into 300 mL of ionized water, and then 200 mL of glacial acetic acid is added, and the mixture is stirred to obtain solution B; solution A is heated to 40° C. in a water bath, solution B is added dropwise while being stirred, pH is adjusted to 3.0 with a 1 mol / L hydrochloric acid solution, 1 g of calcium alginate is added, and the mixture is stirred to fully dissolve the solution, thereby obtaining the nano titanium dioxide-calcium alginate sol.
[0176] Test example
[0177] The injection solutions obtained in Examples 1 to 3 and Comparative Examples 1 to 3 (10,000 vials filled with 4000 mL, filled in ordinary glass ampoules) were subjected to accelerated tests (temperature 40°C, humidity 75%) (temperature 25°C, humidity 60%). The inspection items included: clarity and color of the solution, free sulfate, and insoluble particles. The results are shown in Table 1.
[0178] Table 1. Accelerated test of injection solution
[0179]
[0180]
[0181] As can be seen from Table 1, the injection solutions obtained in Examples 1 to 3 have excellent stability.
[0182] In Comparative Example 1, the pulse electric field treatment was omitted during the refining of enoxaparin sodium, the amino konjac polysaccharide was omitted in the injection prescription of Comparative Example 2, and the activated carbon for injection in Comparative Example 3 was not pretreated. The stability of the injection was significantly deteriorated, indicating that the refining treatment of enoxaparin sodium, the composition of the antioxidant in the injection, and the appropriate subsequent treatment of the activated carbon worked synergistically to reduce impurities and improve the stability of the injection.
[0183] Although the above describes the specific implementation methods of the present invention, it does not limit the scope of protection of the present invention. Based on the technical solution of the present invention, various modifications or variations that can be made by those skilled in the art without creative work are still within the scope of protection of the present invention.
Claims
1. A method for preparing a clear and stable enoxaparin sodium injection, characterized in that: The specific steps are as follows: (1) firstly ultrasonically disperse the crude enoxaparin sodium in a sodium chloride solution to obtain a crude solution, then add anhydrous ethanol to the crude solution, treat it with a pulse electric field, add methanol, let it stand, separate the solid from the liquid, take out the precipitate, and dry it to obtain a refined enoxaparin sodium; (2) Take 70-80% of the prescription amount of water for injection, boil it and place it in a batching tank, cool it naturally to 30-40° C. under nitrogen protection, add glutathione, methionine and amino konjac polysaccharide, and stir until they are completely dissolved; (3) then adding refined enoxaparin sodium, mixing evenly with supercritical carbon dioxide, and adjusting the pH; (4) finally adding the pretreated activated carbon for injection, stirring for adsorption, recovering the activated carbon, filling up the amount of the injection water to the full amount of the prescription, stirring and mixing, filtering through a charged microporous filter membrane of nano-titanium dioxide-calcium alginate, and aseptically filling to obtain the injection solution; In step (1), the process conditions of the pulse electric field treatment are: electric field intensity 10-20 kV / cm, electric field frequency 40-50 Hz, pulse width 2 μs, and treatment time 900-1000 μs; In step (2), the amino konjac polysaccharide is prepared by the following method: first, konjac polysaccharide is added to DMSO, stirred at 45° C. for 3 hours, naturally cooled to room temperature, carbonyl diimidazole is added, stirred at room temperature for 3 hours, then ethylenediamine is added, stirred for 18 hours, dialyzed for 3 days, and vacuum freeze-dried to obtain amino konjac polysaccharide; wherein the mass ratio of konjac polysaccharide, DMSO, carbonyl diimidazole, and ethylenediamine is 1:10-12:2:8-10; In step (4), the pretreatment method of the activated carbon for injection is as follows: first, the carbon dioxide gas is passed into a 2% copper sulfate solution for sterilization and disinfection, then passed into a 1% potassium permanganate solution for removal of residual oxygen, and then foreign matter in the carbon dioxide gas is removed through a 0.22 μm spherical sand core funnel to obtain purified carbon dioxide; then the activated carbon for injection is placed in a tubular furnace, and purified carbon dioxide is passed into it at 50° C., with a flow rate of 100 mL / min, and the treatment time is 30 minutes; the temperature is instantly reduced to -20° C., and the mixture is allowed to stand for 8 hours.
2. The preparation method according to claim 1, characterized in that: The injection comprises, by weight percentage, 9.5-10% of refined enoxaparin sodium, 0.5-0.8% of glutathione, 0.4-0.7% of methionine, 0.3-0.5% of amino konjac polysaccharide, and the remainder is water for injection; wherein the anti-Xa potency of the refined enoxaparin sodium is 110 IU / mg, and the anti-IIa potency is 26 IU / mg.
3. The preparation method according to claim 1, characterized in that: In step (1), the crude enoxaparin sodium is prepared from heparin sodium as a raw material through the steps of salt formation, esterification and depolymerization.
4. The preparation method according to claim 1, characterized in that: In step (1), the usage ratio of crude enoxaparin sodium, sodium chloride solution, anhydrous ethanol and methanol is 1 g: 7-9 mL: 45-50 mL: 10-15 mL, wherein the mass concentration of the sodium chloride solution is 8-10%.
5. The preparation method according to claim 1, characterized in that: In step (1), the process conditions of ultrasonic dispersion are: 500-600W ultrasonic oscillation treatment for 30-40 minutes; The feeding temperature of anhydrous ethanol and methanol is 4°C, the standing temperature is 4°C, and the standing time is 4 to 5 hours; The drying process conditions are: vacuum drying at 60-70°C for 7-8 hours.
6. The preparation method according to claim 1, characterized in that: In step (2), the stirring process conditions are: stirring at 300-400 r / min for 40-50 minutes.
7. The preparation method according to claim 1, characterized in that: In step (3), the specific method of supercritical carbon dioxide mixing is: injecting carbon dioxide, pressurizing to 15-20 MPa, and stirring at 300-400 r / min for 1-2 hours under this condition.
8. The preparation method according to claim 1, characterized in that: In step (4), the nano titanium dioxide-calcium alginate charged microporous filter membrane is prepared by the following method: a polysulfone filter membrane with a pore size of 0.22 μm is completely immersed in 97% concentrated sulfuric acid for 1.5 hours, taken out and rinsed with purified water, and then completely immersed in nano titanium dioxide-calcium alginate sol for 15 minutes, taken out and rinsed with purified water, and after drying, it is completely immersed in a 2.5% calcium chloride aqueous solution for 30 minutes, taken out and allowed to stand for 10 minutes, rinsed with purified water, dried, and sterilized with ethylene oxide.
